Viewing Study NCT06173661


Ignite Creation Date: 2025-12-24 @ 12:55 PM
Ignite Modification Date: 2025-12-28 @ 12:32 PM
Study NCT ID: NCT06173661
Status: RECRUITING
Last Update Posted: 2025-09-23
First Post: 2023-11-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Fremanezumab Treatment of Migraine in Women With Menstrual Migraine Ages 18-45
Sponsor: Brigham and Women's Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module